A prospective, observational study (Anwendungsbeobachtung [AWB]) of the prescribing and administration practices of German gynecologists with Leios® Dragées...
Date First Received: May 31, 2007
Last Updated: December 7, 2007
Verified by: Wyeth, December 2007
Clinical Trial Phase: Phase 4 | Start Date: May 2005
Overall Status: Completed
Brief Summary
Official Title: “A Prospective Observation Study (Anwendungsbeobachtung [AWB]) of the Prescribing and Administration Practices of German Gynecologists With Leios® Dragées/Alesse”
Condition Keyword(s):
Intervention(s):
A prospective, observational study (Anwendungsbeobachtung [AWB]) of the prescribing and administration practices of German gynecologists with Leios® Dragées.
Study Type: Observational
Study Design: Prospective
Intervention(s) in this Clinical Trial
- Drug: Leios/Alesse
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Healthy, women, aged under 40
Gender Eligibility for this Clinical Trial: Female
Minimum Age for this Clinical Trial: N/A
Maximum Age for this Clinical Trial: 40 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers
Clinical Trial Sponsor Information
Lead Sponsor: Wyeth
Overall Clinical Trial Officials and Contacts
Medical Monitor Study Director Wyeth
Additional Information
Information obtained from ClinicalTrials.gov on September 04, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00481650
Study ID Number: 101742
ClinicalTrials.gov Identifier: NCT00481650
Health Authority: Germany: Federal Institute for Drugs and Medical Devices
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
